The BioMelbourne network is delighted to be able to announce that Andrew Maxwell is joining our Board of Directors as of this month.
As the Managing Director of Chatsworth Associates, Andrew has worked with innovators, entrepreneurs and established business owners to plan and execute over $200m in equity and debt raisings, wealth creation plans, corporate transactions and international business development programs.
Chatsworth Associates is a boutique advisory firm providing strategic advice to business owners in emerging and high growth companies innovating in the Bio-Medical, Medical Device, Mobile Health, Health IT, Aged Care, Hospitality, Food Service and Food Technology sectors.
For 10 years, Andrew led the global growth of Global Kinetics Corporation Ltd (GKC) as Managing Director and Chief Executive Officer. The GKC team commercialised a research project emanating from the Florey Institute of Neuroscience and Mental Health and created a global company with a market leading product for the remote measurement and reporting of the movement disorder symptoms of Parkinson s disease – the Parkinson’s KinetiGraph (PKG).